α-Conotoxin PIA TFA

α-Conotoxin PIA TFA is an nAChR (nicotinic acetylcholine receptor) antagonist that primarily targets nAChR subtypes containing α6 and α3 subunits, exhibiting significantly higher selectivity for α6/α3β2β3 nAChR than α3β2 nAChR, and may be used for Parkinson's disease and schizophrenia.

O=C1N2[C@](CCC2)([H])C(N[C@H](C(N[C@@](C(N[C@@H](CSSC[C@]3([H])NC([C@H](CSSC[C@@](NC([C@@H](NC([C@@]4([H])N(CCC4)C([C@@H](NC([C@@H](NC3=O)CO)=O)CC(N)=O)=O)=O)C(C)C)=O)([H])C(N[C@@](C(N[C@H](C(N[C@H](C(N[C@H]1CC(N)=O)=O)CC5=CN=CN5)=O)C(C)C)=O)([H])[C@H](O)C)=O)NC([C@H]6N(CCC6)C([C@H](CC(O)=O)NC([C@@H](N)CCCNC(N)=N)=O)=O)=O)=O)C(N)=O)=O)([H])[C@@H](C)CC)=O)CCC(N)=O)=O.O=C(C(F)(F)F)O